COVID-19 vaccine hesitancy among healthcare workers
•When COVID-19 vaccines became available in France, more than one quarter of healthcare workers (HCWs) were either hesitant (23%) or reluctant (4%) to be vaccinated.•Vaccine hesitancy was more common among HCWs with lower level of medical literacy (auxiliary nurses/technicians), as compared to nurse...
Saved in:
Published in: | Infectious diseases now (Online) Vol. 51; no. 5; pp. 484 - 487 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
France
Elsevier Masson SAS
01-08-2021
Elsevier |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | •When COVID-19 vaccines became available in France, more than one quarter of healthcare workers (HCWs) were either hesitant (23%) or reluctant (4%) to be vaccinated.•Vaccine hesitancy was more common among HCWs with lower level of medical literacy (auxiliary nurses/technicians), as compared to nurses and physicians.•A major controversy over the AstraZeneca vaccine tolerability, with broad media coverage, dramatically increased vaccine hesitancy.
To characterize healthcare workers’ (HCWs) intention to receive the COVID-19 vaccine by the beginning of the vaccine campaign in France.
Data were collected on a self-administered questionnaire through the website of a tertiary care center (February 9–18, 2021).
Among 1,965 respondents, 1,436 (73.1%), 453 (23.1%), and 76 (3.9%) declared themselves in favor, hesitant, or against the COVID-19 vaccine: <60% of auxiliary nurses and technicians intended to be vaccinated, as compared to 60–79% of nurses and support staff, and>80% of medical staff. On multivariate analysis, age, occupation, flu vaccine history, and controversy over the AstraZeneca vaccine tolerability were independently associated with COVID-19 vaccine intention.
Patterns of vaccine hesitancy related to the COVID-19 and influenza vaccines are similar among HCWs. Media communication on vaccine side effects have a dramatic effect on vaccine hesitancy. Efforts are requested to inform HCWs about the risk/benefit balance of COVID-19 vaccines. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 PMCID: PMC8098031 Ronan Garlantezec and Pierre Tattevin co-directed this work. |
ISSN: | 2666-9919 2666-9919 |
DOI: | 10.1016/j.idnow.2021.04.001 |